These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 25970545

  • 1. Comparative Effectiveness of Nutritional and Biological Therapy in North American Children with Active Crohn's Disease.
    Lee D, Baldassano RN, Otley AR, Albenberg L, Griffiths AM, Compher C, Chen EZ, Li H, Gilroy E, Nessel L, Grant A, Chehoud C, Bushman FD, Wu GD, Lewis JD.
    Inflamm Bowel Dis; 2015 Aug; 21(8):1786-93. PubMed ID: 25970545
    [Abstract] [Full Text] [Related]

  • 2. Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn's disease.
    Zhou S, Huang Z, Hou W, Lin Y, Yu J.
    Inflamm Res; 2024 Feb; 73(2):199-209. PubMed ID: 38168701
    [Abstract] [Full Text] [Related]

  • 3. Partial enteral nutrition induces clinical and endoscopic remission in active pediatric Crohn's disease: results of a prospective cohort study.
    Urlep D, Benedik E, Brecelj J, Orel R.
    Eur J Pediatr; 2020 Mar; 179(3):431-438. PubMed ID: 31781933
    [Abstract] [Full Text] [Related]

  • 4. Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.
    Levine A, Wine E, Assa A, Sigall Boneh R, Shaoul R, Kori M, Cohen S, Peleg S, Shamaly H, On A, Millman P, Abramas L, Ziv-Baran T, Grant S, Abitbol G, Dunn KA, Bielawski JP, Van Limbergen J.
    Gastroenterology; 2019 Aug; 157(2):440-450.e8. PubMed ID: 31170412
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Exclusive enteral nutrition continues to be first line therapy for pediatric Crohn's disease in the era of biologics].
    Navas-López VM, Blasco-Alonso J, Lacasa Maseri S, Girón Fernández-Crehuet F, Serrano Nieto MJ, Vicioso Recio MI, Sierra Salinas C.
    An Pediatr (Barc); 2015 Jul; 83(1):47-54. PubMed ID: 24704330
    [Abstract] [Full Text] [Related]

  • 7. Treatment of Active Crohn's Disease in Children Using Partial Enteral Nutrition Combined with a Modified Crohn's Disease Exclusion Diet: A Pilot Prospective Cohort Trial on Clinical and Endoscopic Outcomes.
    Urlep D, Orel R, Kunstek P, Benedik E.
    Nutrients; 2023 Nov 04; 15(21):. PubMed ID: 37960328
    [Abstract] [Full Text] [Related]

  • 8. Oral exclusive enteral nutrition for induction of clinical remission, mucosal healing, and improvement of nutritional status and growth velocity in children with active Crohn's disease - a prospective multicentre trial.
    Matuszczyk M, Meglicka M, Landowski P, Czkwianianc E, Sordyl B, Szymańska E, Kierkuś J.
    Prz Gastroenterol; 2021 Nov 04; 16(4):346-351. PubMed ID: 34976243
    [Abstract] [Full Text] [Related]

  • 9. Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition.
    Afzal NA, Van Der Zaag-Loonen HJ, Arnaud-Battandier F, Davies S, Murch S, Derkx B, Heuschkel R, Fell JM.
    Aliment Pharmacol Ther; 2004 Jul 15; 20(2):167-72. PubMed ID: 15233696
    [Abstract] [Full Text] [Related]

  • 10. Reverse-engineered exclusive enteral nutrition in pediatric Crohn's disease: A pilot trial.
    Lee D, Braly K, Nuding M, Braly I, Hopp C, Twible H, Pope C, Hayden HS, Hoffman L, Zheng H, Wahbeh G, Suskind DL.
    J Pediatr Gastroenterol Nutr; 2024 May 15; 78(5):1135-1142. PubMed ID: 38558411
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach.
    Day AS, Whitten KE, Lemberg DA, Clarkson C, Vitug-Sales M, Jackson R, Bohane TD.
    J Gastroenterol Hepatol; 2006 Oct 15; 21(10):1609-14. PubMed ID: 16928225
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mucosal Healing and Bacterial Composition in Response to Enteral Nutrition Vs Steroid-based Induction Therapy-A Randomised Prospective Clinical Trial in Children With Crohn's Disease.
    Pigneur B, Lepage P, Mondot S, Schmitz J, Goulet O, Doré J, Ruemmele FM.
    J Crohns Colitis; 2019 Jul 25; 13(7):846-855. PubMed ID: 30541015
    [Abstract] [Full Text] [Related]

  • 18. Exclusive Enteral Nutrition versus Infliximab in Inducing Therapy of Pediatric Crohn's Disease.
    Luo Y, Yu J, Lou J, Fang Y, Chen J.
    Gastroenterol Res Pract; 2017 Jul 25; 2017():6595048. PubMed ID: 28928769
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic Efficacy of Oral Enteral Nutrition in Pediatric Crohn's Disease: A Single Center Non-Comparative Retrospective Study.
    Kim HJ, Kim Y, Cho JM, Oh SH, Kim KM.
    Yonsei Med J; 2016 Sep 25; 57(5):1185-91. PubMed ID: 27401650
    [Abstract] [Full Text] [Related]

  • 20. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease.
    Ong C, Lim PT, Logarajah V, Liwanag MJ, Ang BX, Cher Y, Chiou FK, Kader A.
    BMC Gastroenterol; 2018 Dec 12; 18(1):185. PubMed ID: 30541458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.